PTGS2 and neoplasm: The immunosuppressive mediators released by tumor and stromal cells in the TME negatively regulate CTLs-mediated tumor killing by inducing expression of indoleamine 2,3-dioxygenase 1, PD-L1, cyclooxygenase 2, and STAT3 (79, 86).